Muscle Biopsy: A Useful Tool and Approach for Diagnostic Evaluation of Muscle Disease

Article Sidebar

PDF
Keywords:
Muscle biopsy Pathology

Main Article Content

Jariya Waisayarat
Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

Abstract

Muscle biopsy had been used to diagnose muscle disease for a long time because only a few of the disorders show adequate specific clinical features for definite diagnosis. Since the screening of numerous genes is limited to perform, muscle biopsy could be a time and cost effective tool for solving the diagnostic problems. The aim of this review article is to emphasise the importance of muscle biopsy as  a useful tool and approach for diagnostic evaluation of muscle disease. The author describes the procdure for muscle biopsy, specimen handing and the microscopic findings obtained from non-enzyme (tinctorial) and enzymatic histochemical stains correlating with clinical information to achieve the best interpretation results. 

Article Details

How to Cite
1.
Waisayarat J. Muscle Biopsy: A Useful Tool and Approach for Diagnostic Evaluation of Muscle Disease. Rama Med J [Internet]. 2015 Jun. 29 [cited 2024 Apr. 23];38(2):154-72. Available from: https://he02.tci-thaijo.org/index.php/ramajournal/article/view/95930
Issue
Vol. 38 No. 2 (2015): April-June
Section
Review Articles

References

Griesinger W. Ueber muskelhypertrophie. Archiv der Heikunde, 1865;6:1-13.

Duchenne, GBA. Recherches sur la paralysie musculaire pseudohypertrophique ou paralysie myosclérosique. Arch Gén Méd. 1868;11:5-25.

Dubowitz V, Sewry CA, Oldfors A, Lane R. In: Muscle biopsy: A practical approach. Victor Dubowitz, Caroline A, Sewry, Anders Oldfors; with a contribution on toxic and drug-induced myopathies by Russell Lane. 4th ed. Oxford: Saunders Elsevier, 2013:1-94.

Engel WK. Focal myopathic changes produced by electromyographic and hypodermic needles. Arch Neurol. 1967;16(5):509-11.

Kakulas BA, Adams RD. Diseases of muscle. In: Kakulas BA, Adams RD, editors. Pathological foundations of clinical myology. 4th ed. Philadelphia: Harper and Row, 1985.

Waisayarat J, Pornpetchpracha A, Rochanawutanon M. Skeletal muscle studying in non-skeletal disease Thai population: Cadaveric cases. RMJ, 2011;34:190-8.

Edwards R. Percutaneous needle biopsy of skeletal muscle in the diagnosis and research. Lancet. 1971;2:593-5.

Edwards R, Lewis P, Maunder C, Pearse A. Percutaneous needle biopsy in the diagnosis of muscle disease. Lancet. 1973;2:1070-1.

Edwards R, Round J, Jones D. Needle biopsy of skeletal muscle: a review of 10 years’ experience. Muscle Nerve. 1983;6:676-83.

Sewry CA, Jimenez-Mallebrera C, Brown SC, Muntoni F. Diseases of muscle. In: Seth Love, David Louis. David W Ellison, editors. Greenfield’s Neuropathology. 8th ed. London: Hodder Arnold. 2008;1725-820.

Jungbluth H1, Müller CR, Halliger-Keller B, et al. Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores. Neurology. 2002;59(2):284-7.

Magee KR, Shy GM. A new congenital non-progressive myopathy. Brain. 1956;79(4):610-21.

Dubowitz V, Pearse AG. Oxidative enzymes and phosphorylase in central-core disease of muscle. Lancet. 1960;2(7140):23-4.

Engel AG, Gomez MR, Groover RV. Multicore disease. A recently recognized congenital myopathy associated with multifocal degeneration of muscle fibers. Mayo Clin Proc. 1971;46(10):666-81.

Ferreiro A, Quijano-Roy S, Pichereau C, et al. Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies. Am J Hum Genet. 2002;71(4):739-49.

Jungbluth H, Zhou H, Hartley L, et al. Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene. Neurology. 2005;65(12):1930-5.

Monnier N, Ferreiro A, Marty I, Labarre-Vila A, Mezin P, Lunardi J. A homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with multi-minicore disease congenital myopathy with ophthalmoplegia. Hum Mol Genet. 2003;12(10):1171-8.

Ferreiro A, Monnier N, Romero NB, et al. A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene. Ann Neurol. 2002;51(6):750-9.

Fananapazir L, Dalakas MC, Cyran F, Cohn G, Epstein ND. Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A. 1993;90(9):3993-7.

Kaindl AM, Rüschendorf F, Krause S, et al. Missense mutations of ACTA1 cause dominant congenital myopathy with cores. J Med Genet. 2004;41(11):842-8.

Dubowitz V. Pathology of experimentally re-innervated skeletal muscle. J Neurol Neurosurg Psychiatry. 1967;30(2):99-110.

Engel WK, Brooke MH, Nelson PG. Histochemical studies of denervated or tenotomized cat muscle: illustrating difficulties in relating experimental animal conditions to human neuromuscular diseases. Ann N Y Acad Sci. 1966;138(1):160-85.

Shy GM, Engel WK, Somers JE, Wanko T. Nemaline myopathy: A new congenital myopathy Brain. 1963;86:793-810.

Wallgren-Pettersson C, Sewry CA, Nowak KJ, Laing NG. Nemaline myopathies. Semin Pediatr Neurol. 2011 Dec;18(4):230-8. doi: 10.1016/j.spen.2011.10.004.

Wallgren-Pettersson C, Laing NG. Report of the 70th ENMC International Workshop: nemaline myopathy. Neuromuscul Disord. 2000;10(4-5):299-306.

Ryan MM, Schnell C, Strickland CD, et al. Nemaline myopathy: a clinical study of 143 cases. Ann Neurol. 2001;50(3):312-20.

Waisayarat J, Suriyonplengsaeng C, Khongkhatithum C, Rochanawutanon M. Severe congenital nemaline myopathy with primary pulmonary lymphangiectasia: unusual clinical presentation and review of the literature. Diagn Pathol. 2015;10:27. doi:10.1186/s13000-015-0270-8.

Jacques TS, Holton J, Watts PM, Wills AJ, Smith SE, Hanna MG. Tubular aggregate myopathy with abnormal pupils and skeletal deformities. J Neurol Neurosurg Psychiatry. 2002;73(3):324-6.

Kalimo H, Savontaus ML, Lang H, et al. X-linked myopathy with excessive autophagy: a new hereditary muscle disease. Ann Neurol. 1988;23(3):258-65.

Nishino I, Fu J, Tanji K, et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature. 2000;406(6798):906-10.

Spuler S, Carl M, Zabojszcza J, et al. Dysferlin-deficient muscular dystrophy features amyloidosis. Ann Neurol. 2008;63(3):323-8. doi:10.1002/ana.21309.

Rosales XQ, Gastier-Foster JM, Lewis S, et al. Novel diagnostic features of dysferlinopathies. Muscle Nerve. 2010;42(1):14-21. doi:10.1002/mus.21650.

Milone M, Liewluck T, Winder TL, Pianosi PT. Amyloidosis and exercise intolerance in ANO5 muscular dystrophy. Neuromuscul Disord. 2012;22(1):13-5. doi:10.1016/j.nmd.2011.07.005.